These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19882872)

  • 1. [The role of erythrocytes in the system of controlled transport of pharmaceutical agents].
    Provotorov VM; Ivanova GA
    Klin Med (Mosk); 2009; 87(9):4-8. PubMed ID: 19882872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte-based drug delivery.
    Rossi L; Serafini S; Pierigé F; Antonelli A; Cerasi A; Fraternale A; Chiarantini L; Magnani M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):311-22. PubMed ID: 16296756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based drug delivery.
    Pierigè F; Serafini S; Rossi L; Magnani M
    Adv Drug Deliv Rev; 2008 Jan; 60(2):286-95. PubMed ID: 17997501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug, enzyme and peptide delivery using erythrocytes as carriers.
    Millán CG; Marinero ML; Castañeda AZ; Lanao JM
    J Control Release; 2004 Feb; 95(1):27-49. PubMed ID: 15013230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transferrin conjugates in the anticancer therapy].
    Lubgan D; Marczak A; Distel L; Jóźwiak Z
    Postepy Biochem; 2006; 52(1):72-9. PubMed ID: 16869304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cells as carriers for drugs. A method for disseminating chemotherapeutics, hormones, enzymes and other therapeutic agents via the circulatory system. First International Conference on Red Blood Cell Carriers. Bellagio (Italy), February 27-March 2, 1984.
    Bibl Haematol; 1985; (51):1-162. PubMed ID: 4004751
    [No Abstract]   [Full Text] [Related]  

  • 7. An integrated pharmacokinetic and pharmacodynamic approach to controlled drug delivery.
    Breimer DD
    J Drug Target; 1996; 3(6):411-5. PubMed ID: 8863134
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis.
    Gutiérrez Millán C; Zarzuelo Castañeda A; Sayalero Marinero ML; Lanao JM
    Blood Cells Mol Dis; 2004; 33(2):132-40. PubMed ID: 15315791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte carriers.
    Ihler GM; Tsang HC
    Crit Rev Ther Drug Carrier Syst; 1985; 1(2):155-87. PubMed ID: 3913525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocytes - the new application in medicine].
    Szumiło M
    Pol Merkur Lekarski; 2013 Jan; 34(199):5-8. PubMed ID: 23488276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier erythrocytes: an overview.
    Hamidi M; Tajerzadeh H
    Drug Deliv; 2003; 10(1):9-20. PubMed ID: 12554359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics.
    Magnani M; Pierigè F; Rossi L
    Ther Deliv; 2012 Mar; 3(3):405-14. PubMed ID: 22833997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching.
    Magnani M
    Expert Opin Biol Ther; 2012 Feb; 12(2):137-8. PubMed ID: 22230036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier erythrocytes. Clinical pharmacokinetic considerations.
    Tonetti M; De Flora A
    Clin Pharmacokinet; 1993 Nov; 25(5):351-7. PubMed ID: 8287630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Red blood cells as carrier systems for drugs].
    Hellwig U
    Pharmazie; 1990 Nov; 45(11):824-6. PubMed ID: 2100334
    [No Abstract]   [Full Text] [Related]  

  • 17. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution.
    Rossi L; Pierigè F; Antonelli A; Bigini N; Gabucci C; Peiretti E; Magnani M
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):73-87. PubMed ID: 27189231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of exogenous agents in erythrocytes and the circulating survival of carrier erythrocytes.
    DeLoach JR
    J Appl Biochem; 1983 Jun; 5(3):149-57. PubMed ID: 6438049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.